We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$661M
AUM Growth
+$24.1M
Cap. Flow
-$9.32M
Cap. Flow %
-1.41%
Top 10 Hldgs %
41.26%
Holding
75
New
1
Increased
26
Reduced
31
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 43.37%
2 Technology 13.29%
3 Industrials 9.64%
4 Consumer Staples 6.48%
5 Consumer Discretionary 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNX icon
1
Cognex
CGNX
$10.5B
$42.4M 6.41%
769,170
-29,990
-4% -$1.52M
TIF
2
DELISTED
Tiffany & Co.
TIF
$32.5M 4.91%
353,766
+1,030
+0.3% +$94.3K
ADI icon
3
Analog Devices
ADI
$181B
$28.4M 4.3%
329,856
+1,541
+0.5% +$124K
NEOG icon
4
Neogen
NEOG
$2.18B
$26.7M 4.03%
918,424
-627
-0.1% -$16.1K
JNJ icon
5
Johnson & Johnson
JNJ
$599B
$25.9M 3.92%
199,183
+560
+0.3% +$74.2K
RTN
6
DELISTED
Raytheon Company
RTN
$25.1M 3.8%
134,667
-555
-0.4% -$97.8K
IDXX icon
7
Idexx Laboratories
IDXX
$44.5B
$24.1M 3.64%
154,835
+835
+0.5% +$132K
BIIB icon
8
Biogen
BIIB
$29.5B
$23.4M 3.54%
74,804
+100
+0.1% +$29.6K
HON icon
9
Honeywell
HON
$71.7B
$22.4M 3.38%
174,830
-1,013
-0.6% -$126K
MA icon
10
Mastercard
MA
$484B
$22M 3.32%
155,700
+820
+0.5% +$109K
BF.B icon
11
Brown-Forman Class B
BF.B
$12.1B
$21M 3.17%
603,744
-48,364
-7% -$1.57M
DHR icon
12
Danaher
DHR
$142B
$20.9M 3.16%
275,187
+1,720
+0.6% +$127K
NVO
13
Novo Nordisk
NVO
$219B
$19.9M 3.01%
827,930
+8,090
+1% +$183K
PODD icon
14
Insulet
PODD
$11.6B
$16.8M 2.54%
305,260
+585
+0.2% +$31.9K
HSIC icon
15
Henry Schein
HSIC
$9.82B
$16.3M 2.47%
253,569
+497
+0.2% +$33.9K
INGN icon
16
Inogen
INGN
$173M
$15.8M 2.39%
165,955
-185
-0.1% -$17.8K
SBUX icon
17
Starbucks
SBUX
$119B
$14.9M 2.26%
277,915
+40,065
+17% +$2.22M
AMGN icon
18
Amgen
AMGN
$197B
$14.9M 2.25%
79,784
-1,950
-2% -$346K
XRAY icon
19
Dentsply Sirona
XRAY
$2.7B
$14.9M 2.25%
248,398
+5,187
+2% +$308K
ROST icon
20
Ross Stores
ROST
$75.6B
$13.8M 2.09%
214,180
+10,900
+5% +$627K
ABMD
21
DELISTED
Abiomed Inc
ABMD
$13.7M 2.07%
81,155
+125
+0.2% +$18.9K
DXCM icon
22
DexCom
DXCM
$29.2B
$13.2M 2%
1,082,380
+11,600
+1% +$205K
MTD icon
23
Mettler-Toledo International
MTD
$25.7B
$13M 1.96%
20,685
-475
-2% -$285K
ABBV icon
24
AbbVie
ABBV
$448B
$11.4M 1.73%
128,700
+400
+0.3% +$30.4K
STT icon
25
State Street
STT
$50.2B
$10.3M 1.55%
107,624
-550
-0.5% -$51.2K

Similar funds

Tirschwell & Loewy's Q3 2017 Portfolio in Review

As of Q3 2017, Tirschwell & Loewy held 75 positions worth $661M, up 3.8% from $637M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.7%. Tirschwell & Loewy opened 1 new position and exited 1, leaving the 75-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy's largest Q3 2017 buy was United Parcel Service: 6,435 shares worth $773K.
  • Tirschwell & Loewy added most to NEVRO CORP. in Q3 2017, an estimated $4.39M increase.
  • Tirschwell & Loewy's biggest Q3 2017 reduction was SLB Ltd, cutting an estimated $7.59M.
  • Tirschwell & Loewy fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $2.62M.
  • Tirschwell & Loewy's ten largest holdings make up 41% of its $661M portfolio in Q3 2017.
  • Tirschwell & Loewy opened 1 new position and closed 1 in Q3 2017.
  • Tirschwell & Loewy's portfolio value rose 3.8% quarter-over-quarter to $661M.

Based on Tirschwell & Loewy's 13F filing for Q3 2017, filed 24 Oct 2017.